-
Risk Reduction, Clinical Trials Are Focus of Atlanta Community EventCancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
by Kevin McLaughlin
-
Making Clinical Trials More InclusiveBroadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
-
What Do Clinical Trial Endpoints Really Measure?A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.
by Jon Kelvey
-
2018: This Year in Cancer NewsThe Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.
by Cancer Today Staff
-
2018 SABCS: Choosing the Right TreatmentStudies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
by Kate Yandell
-
The Roots of Rural Health DisparitiesNew research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial.
by Cheryl Platzman Weinstock
-
Will Right to Try Increase Access to Experimental Treatments?The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients.
by Marci A. Landsmann
-
Omitting ObesityMany cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.
by Cici Zhang
-
Non–Small Cell Lung Cancer Takes Center StageA trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.
by Brad Jones
-
Pembrolizumab Shows Further Promise for MelanomaIn a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.
by Brad Jones
Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.
by Sandra Gordon
Gaps in Survivorship Care Leave Unmet Needs After Cancer TreatmentA survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
Improving Communication for Deaf Cancer PatientsAfter a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
-
From Discovery to SurvivorshipThe upcoming AACR Patient Advocate Forum will explore how advanced technologies are transforming cancer care, with a focused lens on immunotherapy, precision oncology, imaging, and survivorship.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
